Liftstream is an executive search recruitment company in the life sciences sector
eFFECTOR Therapeutics Secures New Series B Funding
eFFECTOR Therapeutics, an early-stage company focused on the discovery and development of small molecule cancer therapeutics in San Diego, has secured its Series B financing up to USD 56 million. The new funding came from Sectoral Asset Management, a new investor in the syndicate, as well as existing investors. Meanwhile, eFFECTOR Therapeutics appointed Maha Katabi, a partner from Sectoral, to its board of directors.
Wilson Therapeutics Raises $40m to advance development program
Authored by James Sheppard
Posted in Executive Appointments, Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged Abingworth LLP, biotech, Board of Directors, CEO, Chairman, Dr Bali Muralidhar, Dr Genghis Lloyd Harris, Dr Hugh Reinhoff, Dr Marteen Steen, EMA, FDA, HealCap, Imago Bioscience, Investment, Jonas Hansson, Medicon Valley, Mr Jacob Gunterberg, MVM Life Science Partners LLP, orphan drug designation, Series B funding, venture capital, Wilson Therapeutics, Wilson's Disease, WTX101
Leave a comment
GenSight investment profits from gene therapy buzz
Authored by James Sheppard
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases
Tagged Abingworth LLP, Bernard Gilly, Bluebird bio, Boehringer Ingelheim, celgene, Gene therapy, GenSight Biologics, Glybera, Index Ventures, Jen Bennet, Leber’s Hereditary Optic Neuropathy, Novartis Venture Funds, Paris, Professor Jose-Alain Sahel, Transgene, uniQure, University of Pennsylvania, Vision Institute
Leave a comment